Skip to content

Effect of high dose Vitmin D on mortality and morbidity in pulmonary ICU patients.

Effect of high dose Vitamin D3 on mortality, morbidity, length of stay in ICU and mechanical ventilation duration in pulmonary ICU patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014050517583N1
Enrollment
40
Registered
2015-02-19
Start date
2013-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory faillure. Respiratory failure, not elsewhere classified

Interventions

In intervention group single dose of 600,000 units of vitamin D3 will be injected intramuscular..
Treatment - Drugs
In intervention group single dose of 600,000 units of vitamin D3 will be injected intramuscular.

Sponsors

Research deputy of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: ICU admissions with mechanical ventilation, ICU length of stay more than 48 hours; 25-hydroxy vitamin D levels less than 20 ng /ml. Exclusion criteria:Age Younger than 18 years on admission to ICU; ICU length of stay less than 48 hours ; 25-hydroxy vitamin D levels More than 20 ng /ml.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Calcium total and ionized. Timepoint: 0,3,7,14 days after vitd injection. Method of measurement: serum level.;25OH Vit D. Timepoint: 0,3,7,14 days after vitd injection. Method of measurement: Serum level.;Duration of mechanical ventilation. Timepoint: Until discharge from hospital. Method of measurement: Records of patient.

Secondary

MeasureTime frame
Mortality. Timepoint: Until discharge from hospital. Method of measurement: Observations and records of patient.;Hospitalization days. Timepoint: Until discharge from hospital. Method of measurement: Observations and records of patient.;Hospital complications. Timepoint: Until discharge from hospital. Method of measurement: Observations and records of patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mikaeili-haleh

Tabriz medical siense university

Mikaeilih@tbzmed.ac.ir+98 41 3335 7310

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026